Core Viewpoint - Recently, Lanzhou Heavy Industry (603169) delivered 12 pieces of equipment for the raw material adaptability technological transformation project of Fujian Fuhai Chuang Petrochemical Co., Ltd., marking a significant advancement in the company's capabilities and product offerings [1] Group 1: Project Details - The project includes the delivery of a 2 million tons/year AGO (condensate oil) adsorption separation device, a 500,000 tons/year heavy aromatics lightening device, high-pressure vessels, and high-pressure heat exchangers [1] - The technological innovation and industrial chain integration achieved in this project enable a transition from a single "PX-PTA" model to a diversified layout of "aromatics-olefins-high-end chemical products" [1]

Group 1: Company Overview - Longlai Biopharmaceutical Co., Ltd. specializes in the production of cardiovascular drug intermediates, with over 70% of its products exported to Europe, America, and India [1] - The company has established long-term collaborations with top 20 global pharmaceutical companies, leveraging its innovation in raw materials and key intermediates [1] - Longlai Biopharmaceutical invests over 10% of its annual revenue in R&D, focusing on chronic diseases and oncology, and has over 80 domestic and international invention patents [1] Group 2: Industry Development - Jinxian County is enhancing its industrial competitiveness through technological innovation, with a focus on medical devices and advanced manufacturing [1] - The county has established a modern medical device innovation research institute in collaboration with Nanchang University, and has received approval for multiple national and provincial R&D platforms [2] - Jianglian Heavy Industry Group has been recognized in the ENR Global Top 250 International Contractors list for the eighth time, emphasizing its innovation-driven approach and high-quality products [2]